Ildong Pharmaceutical signed agreement with Indonesia's Kalbe Farma to supply hyperlipidemia treatment 'Droptop' to three additional ASEAN countries, achieving 130% annual growth rate in Indonesia over three years.
Korean stock market disclosures on April 13 include capital raises, M&A deals, supply contracts, and financial results from major companies like Korean Air, Samsung suppliers, and pharmaceutical firms.
Ildong Pharmaceutical absorbs its drug R&D subsidiary Unovia to strengthen research capabilities and respond to government drug price reduction policies. Merger ratio is 1:0 with completion scheduled for June 16.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 25 of 40
Get full access to view complete information
Frequently Asked Questions Regarding ILDONG Pharmaceutical Company
Company Overview
1941
Founded
Pharmaceutical Manufacturing
Industry
South Korea
Location
8,094,589
Ranking
200 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding ILDONG Pharmaceutical Company
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.